Skip to content
HowShorted

C4 Therapeutics, Inc. short interest in 2021

In 2021, C4 Therapeutics, Inc.'s disclosed short interest ran from 4.20% of shares outstanding on 15 Jan 2021 to 6.53% on 31 Dec 2021, a change of +2.33 percentage points. The year's high was 8.51% on 31 Mar 2021 and its low 3.58% on 29 Jan 2021, averaging 5.60% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.95 days on 29 Oct 2021. Full history: C4 Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for C4 Therapeutics, Inc. in 2021

2021 in figures

Start of year
4.20% (15 Jan 2021)
End of year
6.53% (31 Dec 2021)
Change
+2.33 pp
High
8.51% (31 Mar 2021)
Low
3.58% (29 Jan 2021)
Average
5.60%
Highest days to cover
17.95 (29 Oct 2021)
SEC filings marked
9

Every report in 2021

C4 Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20214.20%9.19results (8-K)
29 Jan 20213.58%9.68
12 Feb 20213.71%14.83
26 Feb 20214.52%11.07
15 Mar 20214.79%11.1410-K filed, results (8-K)
31 Mar 20218.51%9.63
15 Apr 20216.88%5.96
30 Apr 20216.05%10.42
14 May 20216.16%11.1210-Q filed, results (8-K)
28 May 20215.68%6.46
15 Jun 20215.47%5.02
30 Jun 20216.48%2.87
15 Jul 20216.15%8.90
30 Jul 20216.15%7.65
13 Aug 20215.65%7.0410-Q filed, results (8-K)
31 Aug 20215.00%10.43
15 Sep 20214.68%6.27
30 Sep 20215.50%6.25
15 Oct 20215.48%11.60
29 Oct 20215.58%17.95
15 Nov 20215.69%13.2610-Q filed, results (8-K)
30 Nov 20215.69%12.63
15 Dec 20216.18%7.51
31 Dec 20216.53%7.23

See also: C4 Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.